Hypothesis

Chronic senescent cell accumulation drives Klotho suppression in most tissues, but a distinct senescent subpopulation within the choroid plexus retains α‑Klotho expression and packages it into exosomes that sustain cerebrospinal fluid (CSF) Klotho levels. Broad‑spectrum senolytics (e.g., dasatinib/quercetin, fisetin) eliminate these choroid plexus senescent cells, lowering CSF Klotho and accelerating cognitive decline, whereas Klotho‑sparing senolytic strategies preserve this protective pool.

Mechanistic Rationale

1. Klotho expression in senescent cells is heterogeneous – single‑cell RNA‑seq of aged mouse choroid plexus reveals a cluster of Cdkn2a‑positive cells that still show high Klotho mRNA and protein, unlike senescent kidney or brain parenchymal cells where Klotho is repressed [2].
2. Exosomal Klotho export – these choroid plexus senescent cells secrete exosomes enriched in α‑Klotho that can traverse the CSF‑brain barrier and modulate neuronal Klotho signaling [4].
3. CSF Klotho as a buffer – CSF Klotho correlates with hippocampal synaptic plasticity and resistance to tau pathology; experimental reduction of CSF Klotho impairs memory in young mice [3].
4. Senolytic non‑selectivity – dasatinib/quercetin induces apoptosis in senescent cells irrespective of tissue origin, as shown by uniform p16‑Ink4a reduction across organs [2].

Thus, the net effect of senolysis depends on the balance between removal of Klotho‑suppressing SASP‑producing senescent cells elsewhere and loss of the Klotho‑secreting choroid plexus reservoir.

Testable Predictions

• Prediction 1: In aged mice, systemic senolytic treatment will decrease CSF α‑Klotho levels by ≥30 % relative to vehicle controls.
• Prediction 2: This CSF Klotho drop will correlate with worsened performance in hippocampal‑dependent tasks (e.g., Morris water maze) despite improvements in peripheral markers (e.g., urinary Klotho, bone density).
• Prediction 3: Genetic ablation of senescent cells specifically in the choroid plexus (using Cxcre‑ERT2; p16‑3MR mice) will recapitulate the CSF Klotho reduction and cognitive deficits seen with global senolytics.
• Prediction 4: Intranasal delivery of recombinant α‑Klotho or exosome‑mimetic vesicles loaded with Klotho will rescue the cognitive impairment induced by global senolytics without reversing peripheral benefits.

Experimental Design

1. Animals: 20‑month‑old C57BL/6 mice, divided into four groups (n=12 per group): vehicle, systemic senolytic (dasatinib/quercetin), choroid plexus‑targeted senolysis (Cxcre‑ERT2; p16‑3MR + ganciclovir), and systemic senolytic + intranasal Klotho rescue.
2. Interventions: Administer senolytics for 3 consecutive days, repeat every two weeks for 8 weeks. Intranasal Klotho given three times weekly.
3. Readouts:
   • CSF α‑Klotho measured by ELISA at baseline, week 4, and week 8.
   • Peripheral Klotho (serum, urine) and senescence markers (p16, SASP cytokines) in kidney and liver.
   • Cognitive testing (Morris water maze, novel object recognition) at week 8.
   • Histological assessment of choroid plexus senescence (p16 immunostaining) and exosomal Klotho (CD63/Klotho co‑localization).
4. Statistical analysis: Two‑way ANOVA with post‑hoc Tukey; significance set at p<0.05.

Potential Outcomes and Falsifiability

• If CSF Klotho falls and memory worsens in the systemic senolytic group and is prevented by choroid plexus‑specific senescent cell sparing or Klotho rescue, the hypothesis is supported.
• If CSF Klotho remains unchanged or improves despite global senolysis, or cognitive performance improves parallel to peripheral markers, the hypothesis is falsified, indicating that choroid plexus senescent cells do not contribute a protective Klotho pool.
• If choroid plexus‑targeted senolysis alone reproduces the CSF Klotho drop and cognitive deficit, it confirms the necessity of this compartment for maintaining brain Klotho homeostasis.

This framework directly challenges the assumption that senolytic benefit is universally positive and proposes a tissue‑specific nuance that can be experimentally validated.